They've got double the news for you. Say hi to Doctor Anywhere! They're now set to acquire Singapore's Asian Healthcare Specialists (AHS) in a cash deal valued at around $109M SGD ($76.7M USD).

Oh, and that's not all. They've just raised a $38.8M Series C1 round!

• Not the first. They also acquired Thailand's largest telemedicine startup, Doctor Raksa, last year.
• The offer price for the new deal is about $0.188 SGD ($0.13 USD) per share.
• Doctor Anywhere hit $31.9M SGD ($22.4M USD) in revenue in 2021, over 2.8x growth from 2020.

Investor check. Novo Holdings led the round. Asia Partners, Kamet Capital, Square Peg, IHH Healthcare, Singapore's EDBI and OSK-SBI Venture Partners also joined in!

• They previously raised a $61.9M Series C last year.
• This new C1 funding is to finance the AHS acquisition and speed up growth.

‍

👨🏻‍⚕️🩺 Who's the buyer?

Founded in 2017, Doctor Anywhere started as a side project to help elderly folks who can't leave their homes. A lesson from them? Don't give up on your side hustle.

• They now connect over 2.5M users with over 3,000 general practitioners and specialist doctors!

They initially launched as an online telehealth platform. Now, they've expanded to virtual and in-person clinics, home visits, chronic disease management, mental wellness, medication deliveries and even a marketplace for health products!

‍

🏥 Why the buy?

AHS is a medical services group that offers services across nine specializations.

• They have anesthesia, dermatology, gastroenterology, urology and more.
• They have a network of 14 specialists, one family physician, and one physiotherapist across 12 clinics in Singapore.

The acquisition will allow Doctor Anywhere to offer more holistic and integrated healthcare services. Plus, it'll help them better move into secondary care (aka, specialist/expert care, like when you go to a cardiologist when you have a specific heart-related problem).

• DA hopes to grow their revenue and userbase with this, thanks to more referrals and being able to offer complementary and cross-functional services (basically, because users will be able to use DA for specialist secondary care too).
• Users will get access to even more high-quality, personalized and complex treatments.

‍

🌟 What the future holds

AHS will run as usual. With no major changes, it will stay as a separate entity, won't lay off any staff or redeploy any fixed assets. And for DA, they're on the lookout for even more acquisition opportunities.